Last reviewed · How we verify
NCT06837649
The Effect of Mindfulness-Based Tai Chi Chuan on Mobile Phone Addiction Among Male College Students is Associated With Executive Functions
NA trial testing The mindfulness-based Tai Chi Chuan in Mobile Phone Addiction Behavior in 66 participants. Completed in 3 June 2023.
3 June 2023
Quick facts
| Lead sponsor | Capital University of Physical Education and Sports, China |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 66 |
| Start date | 1 April 2023 |
| Primary completion | 3 June 2023 |
| Estimated completion | 3 June 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- The mindfulness-based Tai Chi Chuan
Conditions studied
- Mobile Phone Addiction Behavior — all drugs for Mobile Phone Addiction Behavior →
Sponsor
Capital University of Physical Education and Sports, China
Who can join
Adults 18 to 21, male only, with Mobile Phone Addiction Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to investigate whether an 8-week mindfulness-based Tai Chi intervention can improve cognitive and executive functions, particularly inhibitory control, and reduce mobile phone addiction in male university students. It will also explore the potential mechanisms by which mindfulness-based Tai Chi affects mobile phone addiction behaviors. The main questions it aims to answer are: Does mindfulness-based Tai Chi improve inhibitory control and reduce mobile phone addiction in male university students? Does mindfulness-based Tai Chi enhance overall executive functions, including inhibition, updating, and shifting abilities? Researchers will compare the experimental group (receiving mindfulness-based Tai Chi intervention) to the control group (maintaining their usual routine without intervention) to see if mindfulness-based Tai Chi leads to greater improvements in cognitive and executive functions and reduces mobile phone addiction. Participants will: Practice mindfulness-based Tai Chi for 8 weeks Complete pre- and post-intervention assessments of mobile phone addiction, mindfulness levels, and executive function Engage in weekly Tai Chi practice sessions Complete self-report diaries of mobile phone usage and mindfulness experiences
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effect of mindfulness-based Tai Chi Chuan on mobile phone addiction among male college students is associated with executive functions.
Li J, Wang D, Bai S, Yang W. · · 2025 · cited 3× · PMID 40338913 · DOI 10.1371/journal.pone.0314211
Verify or expand the search:
- PubMed search for NCT06837649
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Capital University of Physical Education and Sports, China trials
Trials by the same sponsor.
- NCT06848985 — Impact of Combined Aerobic and Resistance Exercise on Autonomic Function and Cardiopulmonary Endurance in Obese College · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06837649 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Capital University of Physical Education and Sports, China
- Last refreshed: 20 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06837649.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing